CG-806
Cat. No.:YN440158
产品名称: | CG-806 |
CAS No.: | 1370466-81-1 |
Chemical Name: | 1-(3-Fluoro-4-(7-(4-methyl-1H-imidazol-2-yl)-1-oxoisoindolin-4-yl)phenyl)-3-(3-(trifluoromethyl)phenyl)urea; CG-806; CG-026806 |
Synonyms: | 7W3FGR71NN;CG026806;1-(3-fluoro-4-(7-(4-methyl-1H-imidazol-2-yl)-1-oxoisoindolin-4-yl)phenyl)-3-(3-(trifluoromethyl)phenyl)urea;1-(3-Fluoro-4-(7-(5-methyl-1H-imidazol-2-yl)-1-oxo-2,3-dihydro-1H-isoindo-1-4-yl)-phenyl)-3-(3-trifluoromethyl-phenyl)urea;Urea |
分子量: | 509.45 |
分子式: | C₂₆H₁₉F₄N₅O₂ |
SMILES: | O=C(NC1=CC=CC(C(F)(F)F)=C1)NC2=CC=C(C3=CC=C(C4=NC=C(C)N4)C5=C3CNC5=O)C(F)=C2 |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | CG-806 是一种口服,有效且非共价的泛-FLT3/泛-BTK抑制剂,对FLT3的IC50值为 0.08 µM。CG-806 对FLT3野生型转染的 Ba/F3 细胞的IC50值为 11 nM。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Hongying Z., et al.: EHA., 265993, 203(2019)
Hongying Z., et al. : Cancer Res., 79, 13(2019)
Hongying Z., et al.:Cancer Res., 78,13(2018)